NAVIGATOR trial: Nearly half of asthma patients improved with tezepelumab treatment - News-Medical.Net
5/16/2022 12:00:00 AM2 years 11 months ago
A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 international conference.
A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 international co… [+3310 chars]
full article...